Skip to main content

Table 3 General information and pharmacoeconomic data on antibacterial prescriptions

From: An outpatient antibacterial stewardship intervention during the journey to JCI accreditation

Indicators First phase Second phase
  (March, 2012) (March, 2013)
Kinds of antibacterials in outpatient pharmacy 38 16
Kinds of the third line antibacterials 1 0
Kinds of the second line antibacterials 17 4
Kinds of the first line antibacterials 20 12
Kinds of i.v. antibacterials 22 0
Kinds of oral antibacterials 16 16
Total number of prescriptions for outpatients 88425 90459
Total number of prescriptions containing antibacterials 11194 8920
Proportion of prescriptions containing antibacterials# 12.7% 9.9%
Proportion of prescriptions containing non-restricted antibacterials# 55.1% 69.6%
Proportion of prescriptions containing restricted antibacterials# 44.7% 30.4%
Proportion of prescriptions containing special-grade antibacterials# 0.14% 0
Total expenditure on antibacterials for outpatients (million CNY) 1.4760 0.9644
Proportion of expenditure on antibacterials relative to all medications 6.9% 4.1%
Proportion of expenditure on i.v. antibacterials relative to all antibacterials 30.5% 0
Sum of DDDs of antibacterials for outpatients 65930 61403
Proportion of DDDs of oral antibacterials for outpatients relative to all antibacterials# 94.0% 100%
  1. Notes: # P < 0.01 (first phase vs second phase). Differences between the two phases were tested for statistical significance using Pearson’s Chi-square test. A P value < 0.05 was considered to be statistically significant. A P value < 0.01 was considered to be highly significant. CNY: Chinese Yuan Renminbi. DDDs: number of defined daily doses (total dose consumed/defined daily dose). Daily expenditure = overall expenditure/DDDs.